News
Biosimilar epoetin shows good safety profile in post-authorization study
2015-01-22 US-based generics manufacturer Hospira announced on 28 April 2014 positive results from a post-authorization observational safety study of its biosimilar epoetin product Retacrit/Silapo (epoetin zeta)… Read More »
FDA releases further biosimilars guidance
2015-01-20 The US Food and Drug Administration (FDA) has issued new draft guidance for biosimilars. The draft guideline, issued in May 2014, explains how to use… Read More »
The Brazilian generics market
2015-01-16 Generics are an effective tool to provide affordable, safe and reliable medicines to patients in Brazil, according to a presentation by Telma Salles [1]. Brazil… Read More »
Biosimilar trastuzumab candidates in phase III development
2015-01-14 The introduction of Herceptin (trastuzumab) revolutionalized the treatment of breast cancer. Prior to its introduction there were few treatment options available to women with human… Read More »
Biosimilars for inflammatory bowel disease in Norway
2015-01-12 Europe approved its first biosimilar monoclonal antibody Inflectra/Remsima (infliximab) on 10 September 2013 [1]. The biosimilar is now recommended by the Norwegian Drug Procurement Cooperation… Read More »
The generics market in Taiwan
2015-01-08 Taiwan is a growing market for pharmaceuticals and the generics market is becoming more competitive in terms of price and quality, according to a presentation… Read More »
UK launches generic medicines forum
2015-01-06 The UK’s drug regulatory agency, the Medicines and Healthcare products Regulatory Agency (MHRA) and the British Generic Manufacturers Association (BGMA) announced on 16 April 2014… Read More »
Attitudes towards generics in Turkey
2015-01-02 Prescribers, pharmacists and patients in Turkey lack knowledge about generics. They may also be misinformed about generics, which can cause hesitation about the use of… Read More »
Biosimilar G-CSF safe for mobilization of stem cells
2014-12-31 A study into the use of granulocyte colony-stimulating factor (G-CSF) biosimilars for peripheral blood haematopoietic stem cell (PBSC) mobilization has found them to be equivalent… Read More »
UK court invalidates Herceptin patents
2014-12-29 A High Court in the UK has overturned two key patents on Roche’s breast cancer blockbuster Herceptin (trastuzumab). The ruling from the London High Court… Read More »
